Steroid-Modulated Transcription Synergistically Forms DNA Double-Strand Breaks With Topoisomerase II Inhibitor.

Area of Science:

• Oncology
• Pharmacology
• Molecular Biology

Background:

• Drug combinations offer enhanced cancer treatment efficacy.
• Medroxyprogesterone acetate (MPA) and etoposide (ETP) demonstrated synergistic antitumor activity.

Purpose of the Study:

• To investigate the underlying mechanisms of the synergistic interaction between MPA and ETP.
• To explore the potential clinical applications of this drug combination.

Main Methods:

• Cell viability assays, cell cycle analysis, and DNA repair assays were performed.
• DNA double-strand breaks (DSBs) and Topoisomerase II (Top2) nuclear localization were detected.
• Genome-wide DSB mapping was utilized to identify break locations.

Main Results:

• MPA synergistically enhanced ETP-induced DSBs, leading to G2/M cell cycle arrest.
• The synergy resulted from increased Top2-DNA covalent complexes, not impaired DSB repair.
• DSBs were predominantly located near promoter regions, suggesting MPA's role in transcriptional modulation.

Conclusions:

• The MPA-ETP synergy operates via a novel mechanism involving enhanced Top2-DNA complex formation and MPA-mediated transcriptional effects.
• This approach differs from conventional DNA damage response strategies.
• The findings support the development of novel therapeutic options for cancer treatment.